tetrabenazine has been researched along with Psychotic Disorders in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (42.86) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burke, J; Factor, SA; Hauser, RA; Jimenez, R; Knesevich, MA; Liang, GS; Marder, SR; O'Brien, CF; Ramirez, PM | 1 |
| Burke, J; Correll, CU; Josiassen, RC; Liang, GS; O'Brien, CF | 1 |
| Burke, J; Josiassen, RC; Kane, JM; Liang, GS; O'Brien, CF | 1 |
| Burke, J; Correll, CU; Kane, JM; Liang, GS; O'Brien, CF | 1 |
| Skaff, R | 1 |
| Correll, CU; Cutler, AJ; Kane, JM; Liang, GS; O'Brien, CF; Sajatovic, M; Stacy, M | 1 |
| Anderson, KE; Bega, D; Davis, MD; Factor, SA; Fernandez, HH; Hauser, RA; Jarskog, LF; Jimenez-Shahed, J; LeDoux, MS; Ondo, WG; Shprecher, DR; Stamler, D; Woods, SW | 1 |
| Dobronevsky, E; Kimiagar, I; Miniovitz, A; Prokhorov, T; Rabey, JM | 1 |
| SCHMITT, W | 1 |
| BURCKARD, E; GEISSMANN, P; MEDHAOUI, M; MONTIGNEAUX, P; PFITZENMEYER, H; PFITZENMEYER, J; SCHAETZEL, JC; SINGER, L | 1 |
| LINGJAERDE, O | 1 |
| BOWERS, CA; HEUSLER, AF; QUICK, R; ULETT, GA; WORD, T; WORD, V | 1 |
| GEISSMANN, P; KAMMERER, T; SINGER, L; WETTA, JM | 1 |
| Fahn, S | 1 |
6 trial(s) available for tetrabenazine and Psychotic Disorders
| Article | Year |
|---|---|
KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia.
Topics: Abnormal Involuntary Movement Scale; Adult; Aged; Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mood Disorders; Psychotic Disorders; Schizophrenia; Tardive Dyskinesia; Tetrabenazine; Treatment Outcome; Valine | 2017 |
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Mood Disorder.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Antipsychotic Agents; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mood Disorders; Outcome Assessment, Health Care; Psychotic Disorders; Schizophrenia; Tardive Dyskinesia; Tetrabenazine; Valine; Vesicular Monoamine Transport Proteins | 2017 |
Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood Disorder.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Antipsychotic Agents; Double-Blind Method; Female; Follow-Up Studies; Humans; Long Term Adverse Effects; Male; Middle Aged; Mood Disorders; Outcome Assessment, Health Care; Psychotic Disorders; Schizophrenia; Tardive Dyskinesia; Tetrabenazine; Valine; Vesicular Monoamine Transport Proteins | 2017 |
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Antipsychotic Agents; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Psychotic Disorders; Schizophrenia; Tardive Dyskinesia; Tetrabenazine; Valine; Vesicular Monoamine Transport Proteins | 2017 |
Abnormal involuntary movement scale in tardive dyskinesia: Minimal clinically important difference.
Topics: Aged; Antipsychotic Agents; Female; Humans; Male; Middle Aged; Minimal Clinically Important Difference; Mood Disorders; Psychotic Disorders; Schizophrenia; Tardive Dyskinesia; Tetrabenazine; Treatment Outcome; Valine; Vesicular Monoamine Transport Proteins | 2019 |
Long-term safety and efficacy of deutetrabenazine for the treatment of tardive dyskinesia.
Topics: Adult; Aged; Anti-Dyskinesia Agents; Antipsychotic Agents; Cytochrome P-450 CYP2D6 Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Mood Disorders; Psychotic Disorders; Tardive Dyskinesia; Tetrabenazine; Treatment Outcome | 2019 |
8 other study(ies) available for tetrabenazine and Psychotic Disorders
| Article | Year |
|---|---|
Valbenazine and Deutetrabenazine as possible treatments for neuroleptic-induced supersensitivity psychosis and antipsychotic dependence.
Topics: Antipsychotic Agents; Dopamine; Humans; Psychotic Disorders; Tardive Dyskinesia; Tetrabenazine; Valine; Vesicular Monoamine Transport Proteins | 2019 |
Rapid improvement of tardive dyskinesia with tetrabenazine, clonazepam and clozapine combined: a naturalistic long-term follow-up study.
Topics: Adrenergic Uptake Inhibitors; Adult; Antipsychotic Agents; Clonazepam; Clozapine; Drug Therapy, Combination; Female; Follow-Up Studies; GABA Modulators; Humans; Male; Middle Aged; Movement Disorders; Psychotic Disorders; Retrospective Studies; Tetrabenazine; Young Adult | 2012 |
[On the pharmacotherapy of psychoses: clinical research on tetrabenazine].
Topics: Mental Disorders; Psychosurgery; Psychotic Disorders; Tetrabenazine; Tranquilizing Agents | 1960 |
[Clinical, biological and electroencephalographic study of the action of tetrabenazine (Ro 956) in various chronic psychoses].
Topics: Electroconvulsive Therapy; Mental Disorders; Psychosurgery; Psychotic Disorders; Tetrabenazine; Tranquilizing Agents | 1962 |
TETRABENAZINE (NITOMAN) IN THE TREATMENT OF PSYCHOSES. WITH A DISCUSSION ON THE CENTRAL MODE OF ACTION OF TETRABENAZINE AND RESERPINE.
Topics: Behavior, Animal; Brain; Chemical Phenomena; Chemistry; Humans; Metabolism; Norepinephrine; Pharmacology; Placebos; Prognosis; Psychotic Disorders; Rats; Research; Reserpine; Schizophrenia; Serotonin; Tetrabenazine; Toxicology | 1963 |
A STUDY OF THE BEHAVIOR AND EEG PATTERNS OF PATIENTS RECEIVING TRANQUILIZERS WITH AND WITHOUT THE ADDITION OF CHLORDIAZEPOXIDE.
Topics: Bipolar Disorder; Chlordiazepoxide; Drug Synergism; Drug Therapy; Electroencephalography; Fluphenazine; Humans; Pharmacology; Phenobarbital; Psychotic Disorders; Schizophrenia; Tetrabenazine; Thioridazine; Tranquilizing Agents | 1964 |
[Use of a new neuroleptic: tetrabenazine. Clinical, biological and electroencephalographic results].
Topics: Antipsychotic Agents; Electroconvulsive Therapy; Psychosurgery; Psychotic Disorders; Tetrabenazine; Tranquilizing Agents | 1962 |
A therapeutic approach to tardive dyskinesia.
Topics: Adult; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Colitis; Depressive Disorder; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Methyltyrosines; Middle Aged; Nausea; Paranoid Disorders; Psychomotor Agitation; Psychoses, Substance-Induced; Psychotic Disorders; Receptors, Dopamine; Reserpine; Tetrabenazine; Time Factors | 1985 |